Axim Biotechnologies Inc (OTCQB:AXIM)

0.58
Delayed Data
As of Oct 18
 0.00 / 0.00%
Today’s Change
0.45
Today|||52-Week Range
2.50
-22.67%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2015

2016

2017

2018
Revenue and IncomeNet Revenues49.1K47.1K47.6K195.6K
 
 
 
 
 
Cost of Goods Sold50.4K154.1K42.9K8.5K
 
 
 
 
 
Depreciation And Amortization1.1K3.4K3.4K12.8K
 
 
 
 
 
 
Operating ExpensesGross Income-2.4K-110.4K1.4K174.3K
 
 
 
 
 
General Expenses9.4M3.0M3.2M5.2M
 
 
 
 
 
Research And Development571.5K235.6K1.4M2.1M
 
 
 
 
 
Total Operating Expenses9.4M3.2M3.2M5.2M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-9.4M-3.1M-3.1M-5.0M
 
 
 
 
 
Extraordinary Charge-652.3K-2.2M0.00-149.0K
 
 
 
 
Interest Expense On Debt43.2K301.4K1.0M1.6M
 
 
 
 
 
Other Expenses0.00-152.1K0.000.00
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-10.1M-5.8M-4.2M-6.8M
 
 
 
 
 
Preferred Dividend---1.5M----
 
 
Net Income-10.1M-5.8M-4.2M-6.8M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS37.1M41.7M53.3M57.3M
 
 
 
 
 
Shares To Calculate EPS Diluted37.1M41.7M53.3M57.3M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.27-$0.17-$0.08-$0.12
 
 
 
 
 
EPS Diluted-$0.27-$0.17-$0.08-$0.12